Free shipping on all orders over $ 500

KU-55933

Cat. No. M1801

All AbMole products are for research use only, cannot be used for human consumption.

KU-55933 Structure
Synonym:

KU55933

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 58  USD58 In stock
5mg USD 48  USD48 In stock
10mg USD 68  USD68 In stock
50mg USD 196  USD196 In stock
100mg USD 328  USD328 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

KU-55933 is a cell-permeable, potent, selective and ATP-competitive inhibitor of ATM (Ataxia telangiectasia mutated), a serine/threonine protein kinase, that exhibits an IC50 of 13 nmol/L and a Ki of 2.2 nmol/L. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3'-kinase-like kinases. Cellular inhibition of ATM by KU-55933 was demonstrated by the ablation of ionizing radiation-dependent phosphorylation of a range of ATM targets, including p53, gammaH2AX, NBS1, and SMC1. KU-55933 did not show inhibition of UV light DNA damage induced cellular phosphorylation events. Exposure of cells to KU-55933 resulted in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Inhibition of ATM by KU-55933 also caused a loss of ionizing radiation-induced cell cycle arrest. By contrast, KU-55933 did not potentiate the cytotoxic effects of ionizing radiation on ataxia-telangiectasia cells, nor did it affect their cell cycle profile after DNA damage. We conclude that KU-55933 is a novel, specific, and potent inhibitor of the ATM kinase.

Product Citations
Customer Product Validations & Biological Datas
Source J Neurooncol (2012). Figure 2. KU-55933
Method clonogenic assay
Cell Lines U251 and U87 malignant glioma cell lines
Concentrations 10 microM
Incubation Time 24 hours or 72 hours
Results U87 cells also were sensitized by KU-55933 treatment, although the extent of sensitization was less profound
Protocol (for reference only)
Cell Experiment
Cell lines LU1205 and WM35 cells
Preparation method Apoptosis studies. Cells were exposed to soluble TRAIL (50 ng/mL) alone or in combination with cycloheximide (2 μg/mL). Different variants of combined treatment were used, including γ-irradiation (5 Gy), in the presence or absence of specific inhibitors of signaling pathways followed by TRAIL treatment. Apoptosis was then assessed by quantifying the percentage of hypodiploid nuclei using fluorescence-activated cell sorting analysis.
Concentrations 10 μM
Incubation time 48 h
Animal Experiment
Animal models LU1205 cells Human melanoma transplant in nude mice.
Formulation DMSO
Dosages 10 μM
Administration
Chemical Information
Molecular Weight 395.49
Formula C21H17NO3S2
CAS Number 587871-26-9
Solubility (25°C) DMSO 39 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ivanov VN, et al. Cancer Res. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.

Related ATM/ATR Products
ART0380 

ART0380 is a potent and selective ATR kinase inhibitor.

KU 59403 

KU 59403 is a potent ATM inhibitor, with IC50 values of 3 nM, 9.1 μM and 10 μM for ATM, DNA-PK and PI3K, respectively.

SKLB-197 

SKLB-197 showed an IC50 value of 0.013 μM against ATR but very weak or no activity against other 402 protein kinases.

ATR-IN-4 

ATR-IN-4 is a potent ATR (Ataxia telangiectasia mutated gene Rad 3-associated kinase) inhibitor.

M3541 

M3541 is a potent, ATP-competitive and selective ATM inhibitor with an IC50 of 0.25 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: KU-55933, KU55933 supplier, ATM/ATR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.